Evidence map›Paper›PMID 33679648›Full record

ArticleFrontiers in microbiology2021

Jiaqi Xu, Feng Dong, Meixian Wu, Rongsheng Tao, Junjie Yang, Mianbin Wu, Yu Jiang, Sheng Yang, Lirong Yang

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Metabolic engineering ofSynthetic and systems biotechnology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Vibrio natriegens: Application of a Fast-Growing Halophilic Bacterium.Advances in biochemical engineering/biotechnology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. UsingBiochemistry · 2024
    Article
  13. Article
  14. Article
  15. UsingbioRxiv : the preprint server for biology · 2023
    Article
  16. Ploidy inGenes · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiaqi XuInstitute of Bioengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China.
Feng DongHuzhou Center of Industrial Biotechnology, Shanghai Institutes for Biological Sciences, Huzhou, China.
Meixian WuKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, China.
Rongsheng TaoHuzhou Center of Industrial Biotechnology, Shanghai Institutes for Biological Sciences, Huzhou, China.
Junjie YangKey Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, China.
Mianbin WuInstitute of Bioengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China.
Yu JiangHuzhou Center of Industrial Biotechnology, Shanghai Institutes for Biological Sciences, Huzhou, China.
Sheng YangHuzhou Center of Industrial Biotechnology, Shanghai Institutes for Biological Sciences, Huzhou, China.
Lirong YangInstitute of Bioengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efficient and novel recombinant protein expression systems can further reduce the production cost of enzymes.

Indexed as

fermentation optimizationpET expression systemrecombinant proteinsynthetic biologyVibrio natriegens

Identifiers

PMID33679648
PMCPMC7933001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.